0.9% Sodium Chloride Injection USP 100 mL bags, Rx only, Baxter Healthcare Corporation Deerfield,...

FDA Drug Recall #D-1128-2018 — Class II — August 21, 2018

Recall Summary

Recall Number D-1128-2018
Classification Class II — Moderate risk
Date Initiated August 21, 2018
Status Terminated
Voluntary Voluntary: Firm initiated

Recalling Firm

Firm Baxter Healthcare Corporation
Location Deerfield, IL
Product Type Drugs
Quantity 33600 bags

Product Description

0.9% Sodium Chloride Injection USP 100 mL bags, Rx only, Baxter Healthcare Corporation Deerfield, IL 60015 USA, NDC 0338-0049-18

Reason for Recall

CGMP Deviations

Distribution Pattern

TX and MS only

Lot / Code Information

Lot #: P380287, Exp. date 12/2019

Other Recalls from Baxter Healthcare Corporation

Recall # Classification Product Date
D-0296-2026 Class II Sterile Water for Irrigation, 250 mL, Single-Do... Dec 22, 2025
D-0596-2025 Class II Acetaminophen Injection 1000 mg/100 mL (10 mg/m... Aug 20, 2025
D-0039-2025 Class II Regadenoson Injection, 0.4 mg/5 mL (0.08 mg/mL)... Oct 30, 2024
D-0649-2024 Class I Heparin (Heparin Sodium in 0.9% Sodium Chloride... Aug 1, 2024
D-0587-2024 Class II Dianeal Low Calcium (2.5 mEq/L) Peritoneal Dial... Jun 17, 2024

Frequently Asked Questions

cGMP stands for Current Good Manufacturing Practice — the FDA's regulations governing drug manufacturing quality. A cGMP recall means the company failed to follow required manufacturing standards. This could involve inadequate testing, poor environmental controls, documentation failures, or process deviations. cGMP recalls do not always mean the product is directly harmful — in many cases, quality records are insufficient to confirm the product meets specifications. However, the FDA requires a recall because without proper documentation, product quality cannot be assured. These are often Class II or Class III recalls.

Not necessarily. Many drug recalls are initiated because of quality system failures or test results that suggest a product might not meet specifications — even if no patients have reported harm. The FDA uses a precautionary approach: if there is reason to believe quality standards were not met, a recall is required regardless of whether adverse effects have been reported. Class I recalls typically involve a reasonable probability of harm; Class II recalls may cause temporary health issues; Class III recalls are for products unlikely to cause adverse health consequences but that still violate regulations.

Pharmacies typically receive recall notices directly from drug wholesalers and manufacturers within days of the recall being announced. Your pharmacist can look up whether any product in your prescription history matches a recalled lot number. For current recalls, the FDA publishes updates at FDA.gov/safety/recalls-market-withdrawals-safety-alerts and sends MedWatch email alerts for significant drug safety issues. You can sign up for MedWatch alerts at FDA.gov. Most major pharmacy chains also have their own recall notification systems that automatically alert pharmacists when a recalled product is in their inventory.

What Should You Do?

Stop using this medication if affected by this recall. Contact your pharmacist or prescribing doctor immediately for guidance. Do not flush medications — use a drug take-back program.